MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2020 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
21.6 M |
Marktkapitalisierung |
$ 231 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Lipocine
LPCN
|
$ 1.43 | -2.05 % | $ 7.79 M | Nasdaq Global Select Market | USA |
 |
Seres Therapeutics
MCRB
|
$ 2.11 | 7.65 % | $ 18.7 M | Nasdaq Global Select Market | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
$ 400.41 | 1.03 % | $ 8.98 B | Nasdaq Global Select Market,SPB | USA |
 |
Mesoblast Limited
MESO
|
$ 14.3 | -3.18 % | $ 17.3 B | Nasdaq Global Select Market |  Australia |
 |
CEL-SCI Corporation
CVM
|
$ 1.39 | -1.42 % | $ 11.1 M | NYSE American,SPB | USA |
 |
Inventiva S.A.
IVA
|
$ 3.88 | -3.72 % | $ 232 M | Nasdaq Global Market |  France |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.41 | -1.16 % | $ 757 M | Nasdaq Global Select Market | USA |
 |
Eton Pharmaceuticals
ETON
|
$ 50.68 | -0.53 % | $ 1.36 B | Nasdaq Global Market | USA |
 |
IDEAYA Biosciences
IDYA
|
$ 32.29 | 3.06 % | $ 2.86 B | Nasdaq Global Select Market | USA |
 |
Lantern Pharma
LTRN
|
$ 0.58 | -3.6 % | $ 6.32 M | Nasdaq Global Select Market | USA |
 |
Foghorn Therapeutics
FHTX
|
$ 2.11 | -1.17 % | $ 133 M | Nasdaq Global Market | USA |
 |
Minerva Neurosciences
NERV
|
$ 2.51 | 6.81 % | $ 21.2 M | Nasdaq Global Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 7.41 | 2.21 % | $ 427 M | Nasdaq Global Select Market |  Israel |
 |
Neurocrine Biosciences
NBIX
|
$ 166.08 | 0.75 % | $ 16.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 29.58 | 3.57 % | $ 1.41 T | Nasdaq Global Select Market | France |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.3 | 4.78 % | $ 239 M | Nasdaq Global Select Market |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
$ 7.73 | 5.7 % | $ 1.12 B | Nasdaq Global Select Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 1.49 | 1.71 % | $ 541 M | Nasdaq Global Select Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 8.47 | 2.05 % | $ 10 M | Nasdaq Global Select Market | USA |
 |
Nurix Therapeutics
NRIX
|
$ 15.72 | -39.12 % | $ 1.36 B | Nasdaq Global Select Market,SPB | USA |
 |
Nkarta
NKTX
|
$ 1.73 | 12.75 % | $ 128 M | Nasdaq Global Select Market | USA |
 |
MacroGenics
MGNX
|
$ 2.31 | -0.86 % | $ 146 M | Nasdaq Global Select Market | USA |
 |
ImmuCell Corporation
ICCC
|
$ 10.36 | 1.07 % | $ 93.5 M | Nasdaq Global Select Market | USA |
|
Nuvation Bio
NUVB
|
$ 4.7 | 0.11 % | $ 1.61 B | NYSE | USA |
 |
Novo Nordisk A/S
NVO
|
$ 42.28 | 5.19 % | $ 188 B | NYSE |  Danmark |
 |
Marker Therapeutics
MRKR
|
$ 1.0 | 2.25 % | $ 15.3 M | Nasdaq Global Market | USA |
 |
NextCure
NXTC
|
$ 5.91 | 0.34 % | $ 16.8 M | Nasdaq Global Select Market | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 7.54 | 2.59 % | $ 656 M | Nasdaq Global Select Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 134.83 | 6.09 % | $ 11.4 B | Nasdaq Global Market | USA |
 |
Oragenics
OGEN
|
$ 0.38 | 1.35 % | $ 820 K | NYSE American | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.75 | 14.37 % | $ 358 M | Nasdaq Global Select Market | USA |
 |
Passage Bio
PASG
|
$ 3.51 | 3.24 % | $ 11.3 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 65.67 | 7.99 % | $ 8.94 B | Nasdaq Global Select Market | USA |
 |
Precigen
PGEN
|
$ 5.05 | -3.76 % | $ 1.58 B | Nasdaq Global Select Market | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.86 | -4.65 % | $ 5.15 M | Nasdaq Capital Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 284.45 | 1.4 % | $ 6.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 4.08 | 7.94 % | $ 314 M | Nasdaq Global Select Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.41 | 2.55 % | $ 149 M | Nasdaq Global Market |  Niderland |
 |
Ocular Therapeutix
OCUL
|
$ 7.14 | 4.69 % | $ 1.34 B | Nasdaq Global Select Market | USA |
 |
PolyPid Ltd.
PYPD
|
$ 5.69 | 4.21 % | $ 93 M | Nasdaq Global Select Market | Israel |
 |
Outlook Therapeutics
OTLK
|
$ 0.46 | -0.8 % | $ 16 M | Nasdaq Global Select Market | USA |
 |
uniQure N.V.
QURE
|
$ 23.04 | -3.48 % | $ 1.32 B | Nasdaq Global Select Market | Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 17.14 | 3.07 % | $ 1.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Regeneron Pharmaceuticals
REGN
|
$ 931.5 | -4.3 % | $ 97.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Rafael Holdings
RFL
|
$ 1.1 | 1.97 % | $ 56.5 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 7.61 | -0.33 % | $ 392 M | Nasdaq Global Select Market,SPB | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 3.0 | 4.17 % | $ 2.04 M | Nasdaq Global Select Market |  China |
 |
Rigel Pharmaceuticals
RIGL
|
$ 51.18 | 4.75 % | $ 921 M | Nasdaq Global Select Market | USA |
 |
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | USA |
 |
Генетико
GECO
|
- | - | - | MOEX |  Russia |